Virtus Biotech ETF (BBP)
NYSEARCA: BBP · Real-Time Price · USD
83.32
-0.30 (-0.36%)
Apr 28, 2026, 4:00 PM EDT - Market closed
-0.36% (1D)
| Assets | $61.54M |
| Expense Ratio | 0.34% |
| PE Ratio | n/a |
| Shares Out | 700,004 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | n/a |
| Volume | 3,403 |
| Open | 83.76 |
| Previous Close | 83.62 |
| Day's Range | 83.18 - 84.53 |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta | 0.61 |
| Holdings | 63 |
| Inception Date | Dec 17, 2014 |
About BBP
Fund Home PageThe Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.
Asset Class Equity
Category Health
Region North America
Stock Exchange NYSEARCA
Ticker Symbol BBP
ETF Provider Virtus Investment Partners
Index Tracked LifeSci Biotechnology Products Index
Top 10 Holdings
25.52% of assets| Name | Symbol | Weight |
|---|---|---|
| ImmunityBio, Inc. | IBRX | 5.51% |
| Moderna, Inc. | MRNA | 2.85% |
| Apellis Pharmaceuticals, Inc. | APLS | 2.58% |
| Iovance Biotherapeutics, Inc. | IOVA | 2.51% |
| Mirum Pharmaceuticals, Inc. | MIRM | 2.25% |
| Roivant Sciences Ltd. | ROIV | 2.02% |
| Novavax, Inc. | NVAX | 1.97% |
| Axsome Therapeutics, Inc. | AXSM | 1.96% |
| Zai Lab Limited | ZLAB | 1.96% |
| Ligand Pharmaceuticals Incorporated | LGND | 1.91% |
News
Late-stage biotech ETFs rally Monday on virus treatment hopes
Late-stage biotech exchange-traded funds were among the day's biggest gainers Monday as investors pinned their hopes on medical responses to the novel coronavirus. The ALPS Medical Breakthroughs ETF ...
Other symbols: SBIO
6 years ago - Market Watch